Rockwood N. Efficient likelihood estimation of generalized structural equation models with a mix of normal and nonnormal responses. Psychometrika. 2021 Jun;86(2):642-67. doi: 10.1007/s11336-021-09770
Rockwood NJ. Maximum likelihood estimation of multilevel structural equation models with random slopes for latent covariates. Psychometrika. 2020 Jun;85(2):275-300. doi: 10.1007/s11336-020-09702-9
Wilson M, Lucas A, Cameron A, Luo M. Budget impact of adding vedolizumab to a health plan formulary as a first-line biologic option for ulcerative colitis and crohn's disease. Am Health Drug Benefits. 2018 Jul;11(5):253-62.
Pujol J, Fenoll R, Macia D, Martinez-Vilavella G, Alvarez-Pedrerol M, Rivas I, Forns J, Deus J, Blanco-Hinojo L, Querol X, Sunyer J. Airborne copper exposure in school environments associated with poorer motor performance and altered basal ganglia. Brain Behav. 2016 Apr 22;e00467. doi: 10.1002/brb3.467
Harris JB, Ward MA, Schwab P. Is response-guided therapy being applied in the clinical setting? The hepatitis C example. Am Health Drug Benefits. 2015 Feb;8(1):22-8.
Sacco P, Capkun-Niggli G, Zhang X, Jose R. The economic burden of fragile x syndrome: healthcare resource utilization in the United States. Am Health Drug Benefits. 2013 Mar;6(2):73-83.
Lennert B, Bibeau W, Farrelly E, Sacco P, Schoor T. Assessment of treatment patterns and patient outcomes in levodopa-induced dyskinesias (ASTROID): a US chart review study. Am Health Drug Benefits. 2012 Sep;5(6):347-58.
Yung YF, Thissen D, McLeod LD. On the relationship between the higher-order factor model and the hierarchical factor model. Psychometrika. 1999 Jun;64:113-28.
Burke GL, Anthony MS, Vitolins M. Dietary soy protein and lipids: a strategy for primary prevention of cardiovascular disease? Current opinion in endocrinology diabetes and obesity. 1996 Dec;3(6):508-13.